Javascript must be enabled to continue!
Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
View through CrossRef
Abstract
Background: ALT value is often used to reflect the hepatic inflammation and injury in NAFLD patients, but many studies proved that ALT values were normal in many NAFLD patients. The aim of this study was to identify the summarized proportion of NAFLD patients with normal ALT value in the overall NAFLD patients. Methods: Electronic databases PubMed, EMBASE, Ovid, and the Cochrane Library were searched for potential studies published from January 1, 2000 to September 30, 2019. Studies that have reported the number of NAFLD or NASH patients with normal and abnormal ALT value were included and analyzed. Abstracts, reviews, case reports, and letters were excluded. Results: A total of 11 studies with 4084 patients were included for assessing the summarized proportion of NAFLD patients with normal ALT in overall NAFLD patients. As the results shown, the summarized proportion of NAFLD patients with normal ALT value in overall NAFLD patients was 25% (95%CI: 20%-31%) which was calculated by the random-effects model. The summarized proportion of NASH patients with normal ALT value in overall NASH patients was 19% (95%CI: 13%-27%). Subgroup analysis includes region, study type, diagnostic method, and group size were conducted to investigate the resource of heterogeneity in the summarized proportion of NAFLD and NASH patients with normal ALT value. Conclusions: 25% NAFLD patients and 19% NASH patients possess the normal ALT value in the clinical manifestation. The value of ALT in the clinical diagnosis of NAFLD and NASH remains need be further testified.
Springer Science and Business Media LLC
Title: Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
Description:
Abstract
Background: ALT value is often used to reflect the hepatic inflammation and injury in NAFLD patients, but many studies proved that ALT values were normal in many NAFLD patients.
The aim of this study was to identify the summarized proportion of NAFLD patients with normal ALT value in the overall NAFLD patients.
Methods: Electronic databases PubMed, EMBASE, Ovid, and the Cochrane Library were searched for potential studies published from January 1, 2000 to September 30, 2019.
Studies that have reported the number of NAFLD or NASH patients with normal and abnormal ALT value were included and analyzed.
Abstracts, reviews, case reports, and letters were excluded.
Results: A total of 11 studies with 4084 patients were included for assessing the summarized proportion of NAFLD patients with normal ALT in overall NAFLD patients.
As the results shown, the summarized proportion of NAFLD patients with normal ALT value in overall NAFLD patients was 25% (95%CI: 20%-31%) which was calculated by the random-effects model.
The summarized proportion of NASH patients with normal ALT value in overall NASH patients was 19% (95%CI: 13%-27%).
Subgroup analysis includes region, study type, diagnostic method, and group size were conducted to investigate the resource of heterogeneity in the summarized proportion of NAFLD and NASH patients with normal ALT value.
Conclusions: 25% NAFLD patients and 19% NASH patients possess the normal ALT value in the clinical manifestation.
The value of ALT in the clinical diagnosis of NAFLD and NASH remains need be further testified.
Related Results
Alts and Automediality: Compartmentalising the Self through Multiple Social Media Profiles
Alts and Automediality: Compartmentalising the Self through Multiple Social Media Profiles
IntroductionAlt, or alternative, accounts are secondary profiles people use in addition to a main account on a social media platform. They are a kind of automediation, a way of rep...
Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
Abstract
Background ALT value is often used to reflect hepatic inflammation and injury in NAFLD patients, but many studies suggested that ALT values are normal in many NAFL...
The NAFLD fibrosis score : a prognostic predictor for mortality and liver complications among NAFLD patients
The NAFLD fibrosis score : a prognostic predictor for mortality and liver complications among NAFLD patients
Background: The prognostic indicators for long-term outcomes of non alcoholic fatty liver disease (NAFLD) patients have not been well studied. We aimed to validate the NAFLD Fibros...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Clinical research for the significance of inflammatory factors and adiponectin in type 2 diabetes complicated with non-alcoholic fatty liver disease
Clinical research for the significance of inflammatory factors and adiponectin in type 2 diabetes complicated with non-alcoholic fatty liver disease
Objective
To investigate the clinical significance of inflammatory factors and adiponectin in type 2 diabetes milletus complicated with non-alcoholic fatty liver ...
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
<span style="font-size:11pt"><span style="background:#f9f9f4"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><spa...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Cumulative exposure to AHA Life's Essential 8 is associated with nonalcoholic fatty liver disease: a large cohort study
Cumulative exposure to AHA Life's Essential 8 is associated with nonalcoholic fatty liver disease: a large cohort study
Abstract
Background and Aim
We aimed to explore the associations of baseline and cumulative cardiovascular health with nonalcoholic fatty liver dise...

